- Home
- FTHM vs ACXP Comparison
FTHM vs ACXP Comparison
Compare FTHM & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- ACXP
- Stock Information
- Founded
- FTHM 2010
- ACXP 2017
- Country
- FTHM United States
- ACXP United States
- Employees
- FTHM N/A
- ACXP N/A
- Industry
- FTHM Real Estate
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- FTHM Finance
- ACXP Health Care
- Exchange
- FTHM Nasdaq
- ACXP Nasdaq
- Market Cap
- FTHM 33.6M
- ACXP 8.4M
- IPO Year
- FTHM 2020
- ACXP 2021
- Fundamental
- Price
- FTHM $1.27
- ACXP $0.47
- Analyst Decision
- FTHM Buy
- ACXP Strong Buy
- Analyst Count
- FTHM 1
- ACXP 2
- Target Price
- FTHM $2.50
- ACXP $10.00
- AVG Volume (30 Days)
- FTHM 87.1K
- ACXP 18.7M
- Earning Date
- FTHM 08-11-2025
- ACXP 08-08-2025
- Dividend Yield
- FTHM N/A
- ACXP N/A
- EPS Growth
- FTHM N/A
- ACXP N/A
- EPS
- FTHM N/A
- ACXP N/A
- Revenue
- FTHM $357,816,000.00
- ACXP N/A
- Revenue This Year
- FTHM $32.40
- ACXP N/A
- Revenue Next Year
- FTHM $18.04
- ACXP N/A
- P/E Ratio
- FTHM N/A
- ACXP N/A
- Revenue Growth
- FTHM 5.80
- ACXP N/A
- 52 Week Low
- FTHM $0.65
- ACXP $0.30
- 52 Week High
- FTHM $3.37
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- FTHM 53.30
- ACXP 52.38
- Support Level
- FTHM $1.27
- ACXP $0.45
- Resistance Level
- FTHM $1.39
- ACXP $0.59
- Average True Range (ATR)
- FTHM 0.10
- ACXP 0.08
- MACD
- FTHM 0.01
- ACXP -0.01
- Stochastic Oscillator
- FTHM 61.54
- ACXP 27.06
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.